Sees FY23 Adjusted EBITDA to be greater than $425 million
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SGRY:
- Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2022 Results; Sets 2023 Guidance
- Surgery Partners, Inc. Announces Fourth Quarter 2022 Earnings Release Date and Conference Call Details
- Surgery Partners reaffirms 2022 revenue view $2.5B-$2.55B, consensus $2.52B
- Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance
- Surgery Partners, Inc. To Present At Upcoming Investor Conference